查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1518752

日本糖尿病市場報告：2024-2032

Japan Diabetes Market Report: 2024-2032
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3個工作天內

價格

2023 年日本糖尿病市場規模達到 54IMARC Group美元。

糖尿病是指人體產生和回應胰島素激素的能力受損的一種慢性疾病。這導致碳水化合物代謝異常和血液中葡萄糖水平升高。在日本，很大一部分人口年齡超過 60 歲，是第 2 型糖尿病較為流行的年齡。此外，由於日本飲食中含有很大一部分精製碳水化合物，如白米和麵條，這使得人們患糖尿病和加重糖尿病的風險更高。

日本糖尿病市場促進因素：

隨著西方美食影響力的增強、工作時間的增加以及國內農業產量的下降，消費者現在開始依賴加工食品和快餐，如漢堡、玉米捲、熱狗和披薩。由於這些食品富含碳水化合物、鈉和防腐劑，其消費量的增加導致該國糖尿病病例增加。導致糖尿病病例增加的其他因素包括肥胖人口的增加和久坐的生活方式。然而，為了最大限度地減少該國糖尿病的盛行率，日本政府正在採取多項措施。例如，它透過全民健保系統向在日本居住一年以上的公民和非公民提供健康保險。

本報告回答的關鍵問題：

  • 到目前為止，日本糖尿病市場的表現如何？
  • COVID-19 對日本糖尿病市場有何影響？
  • 日本糖尿病市場的熱門細分市場有哪些？
  • 日本糖尿病市場價值鏈的各個階段是什麼？
  • 日本糖尿病市場的關鍵促進因素和挑戰是什麼？
  • 日本糖尿病市場的結構如何？
  • 日本糖尿病市場的競爭程度如何？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：糖尿病概述

  • 什麼是糖尿病？
  • 糖尿病診斷與治療
    • 診斷
    • 治療
  • 糖尿病併發症

第 6 章：日本糖尿病流行病學

  • 糖尿病人口和盛行率
  • 人口和盛行率：按糖尿病類型（1 型和 2 型）
  • 人口和盛行率：按地區
  • 人口及盛行率：依性別分類
  • 人口和盛行率：依年齡層別

第 7 章：日本糖尿病市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測
  • SWOT分析
    • 概述
    • 優勢
    • 弱點
    • 機會
    • 威脅
  • 價值鏈分析
  • 波特五力分析
    • 概述
    • 買家的議價能力
    • 供應商的議價能力
    • 競爭程度
    • 新進入者的威脅
    • 替代品的威脅
  • 市場區隔：按細分市場
    • 日本口服降血糖藥市場
      • 歷史市場趨勢
      • 市場區隔：依類別
      • 關鍵參與者的市場佔有率
      • 市場預測
    • 日本胰島素市場
      • 歷史市場趨勢
      • 市場區隔：依類別
      • 關鍵參與者的市場佔有率
      • 市場預測

第 8 章：競爭格局

  • 市場結構
  • 關鍵參與者簡介
Product Code: SR112024A561

The Japan diabetes market size reached US$ 5.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.3 Billion by 2032, exhibiting a growth rate (CAGR) of 3.3% during 2024-2032.

Diabetes refers to a chronic disease in which the ability of a human body to produce and respond to insulin hormone becomes impaired. This results in abnormal metabolism of carbohydrates and elevated levels of glucose in the blood. In Japan, a large section of the population is over 60 years, an age when type-2 diabetes becomes more prevalent. Moreover, as the Japanese diet consists of a significant portion of refined carbohydrates, like white rice and noodles, it puts the population at a higher risk of developing and aggravating diabetes.

Japan Diabetes Market Drivers:

With the growing influence of western cuisines, increasing working hours and declining domestic agricultural production, consumers are now relying on processed food products and fast-food like burger, taco, hotdog and pizza. As these food products are high in carbohydrates, sodium and preservatives, their rising consumption has increased the cases of diabetes in the country. The other factors that are contributing to the increasing cases of diabetes include growing obese population and sedentary lifestyles. However, to minimize the prevalence of diabetes in the country, the Government of Japan is undertaking several initiatives. For instance, it is offering health insurance to both the citizens and non-citizens residing for more than a year in Japan through their universal health care system.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the Japan diabetes market report, along with forecasts for the period 2024-2032. Our report has categorized the market based on segment.

Breakup by Segment:

Oral Antidiabetics

Insulin

Currently, insulin represents the dominant segment, accounting for the majority of the total market share. Insulin in Japan is usually taken through pens, pumps, syringes and jet injectors as they offer convenience to the patients. Increasing diagnostic rates and awareness among patients are enabling them to incorporate insulin therapy for treating diabetes.

Competitive Landscape:

The competitive landscape of the market has been analyzed in the report with detailed profiles of key players operative in the industry.

Key Questions Answered in This Report:

  • How has the Japan diabetes market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan diabetes market?
  • Which are the popular segments in the Japan diabetes market?
  • What are the various stages in the value chain of the Japan diabetes market?
  • What are the key driving factors and challenges in the Japan diabetes market?
  • What is the structure of the Japan diabetes market and who are the key players?
  • What is the degree of competition in the Japan diabetes market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Diabetes Disease Overview

  • 5.1 What is Diabetes?
  • 5.2 Diabetes Diagnosis and Treatment
    • 5.2.1 Diagnosis
    • 5.2.2 Treatment
  • 5.3 Diabetes Complications

6 Japan Diabetes Epidemiology

  • 6.1 Diabetes Population and Prevalence Rates
  • 6.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
  • 6.3 Population and Prevalence Rates by Region
  • 6.4 Population and Prevalence Rates by Gender
  • 6.5 Population and Prevalence Rates by Age Group

7 Japan Diabetes Market

  • 7.1 Market Overview
  • 7.2 Market Performance
  • 7.3 Impact of COVID-19
  • 7.4 Market Forecast
  • 7.5 SWOT Analysis
    • 7.5.1 Overview
    • 7.5.2 Strengths
    • 7.5.3 Weaknesses
    • 7.5.4 Opportunities
    • 7.5.5 Threats
  • 7.6 Value Chain Analysis
  • 7.7 Porter's Five Forces Analysis
    • 7.7.1 Overview
    • 7.7.2 Bargaining Power of Buyers
    • 7.7.3 Bargaining Power of Suppliers
    • 7.7.4 Degree of Competition
    • 7.7.5 Threat of New Entrants
    • 7.7.6 Threat of Substitutes
  • 7.8 Market Breakup by Segment
    • 7.8.1 Japan Oral Antidiabetics Market
      • 7.8.1.1 Historical Market Trends
      • 7.8.1.2 Market Breakup by Class
      • 7.8.1.3 Market Shares of Key Players
      • 7.8.1.4 Market Forecast
    • 7.8.2 Japan Insulin Market
      • 7.8.2.1 Historical Market Trends
      • 7.8.2.2 Market Breakup by Class
      • 7.8.2.3 Market Shares of Key Players
      • 7.8.2.4 Market Forecast

8 Competitive Landscape

  • 8.1 Market Structure
  • 8.2 Profiles of Key Players

List of Figures

  • Figure 1: The Impact of Diabetes in the Human Body
  • Figure 2: Diabetes Complications
  • Figure 3: Global: Breakup of Diabetes Patients by Region, (in %) 2023 & 2032
  • Figure 4: Body Mass Index and Relative risk of Type-2 Diabetes
  • Figure 5: Japan: Total Number of Diabetes Patients (in 000), 2018-2023
  • Figure 6: Japan: Total Number of Diabetes Patients Forecast (in 000), 2024-2032
  • Figure 7: Japan (Type1 & Type2): Total Number of Diabetes Patients (in 000), 2018-2023
  • Figure 8: Japan (Type1 & Type2): Total Number of Diabetes Patients Forecast (in 000), 2024-2032
  • Figure 9: Japan (Urban & Rural): Total Number of Diabetes Patients (in 000), 2018-2023
  • Figure 10: Japan (Urban & Rural): Total Number of Diabetes Patients Forecast (in 000), 2024-2032
  • Figure 11: Japan (Male & Female): Total Number of Diabetes Patients (in 000), 2018-2023
  • Figure 12: Japan (Male & Female): Total Number of Diabetes Patients Forecast (in 000), 2024-2032
  • Figure 13: Japan: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in 000), 2018-2023
  • Figure 14: Japan: Total Number of Diabetes Patients Forecast by Age Group (20-39), (40-59) & (60-79) (in 000), 2024-2032
  • Figure 15: Japan: Diabetes Drug Industry Overview
  • Figure 16: Japan: Diabetes Drug Market: Sales Value (in Billion US$), 2018-2023
  • Figure 17: Japan: Diabetes Drug Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 18: Japan: Diabetes Drug Market: SWOT Analysis
  • Figure 19: Japan: Diabetes Drug Market: Value Chain Analysis
  • Figure 20: Japan: Diabetes Drug Market: Porters Five Forces Analysis
  • Figure 21: Japan: Diabetes Drug Market: Breakup of Insulin and Oral Antidiabetics (in %), 2018-2023
  • Figure 22: Japan: Diabetes Drug Market Forecast: Breakup of Insulin and Oral Antidiabetics (in %), 2024-2032
  • Figure 23: Japan: Oral Antidiabetics Market: Sales Value (in Million US$), 2018-2023
  • Figure 24: Japan: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2018 & 2023
  • Figure 25: Japan: Oral Anti-diabetics Market: Sales Share of Key Players (in %)
  • Figure 26: Japan: Oral Antidiabetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Japan: Insulin Market: Sales Value (in Million US$), 2018-2023
  • Figure 28: Japan: Breakup of Insulin Market by Class (in %), 2023
  • Figure 29: Japan: Insulin Market: Sales Share of Key Players (in %)
  • Figure 30: Japan: Insulin Market Forecast: Sales Value (in Million US$), 2024-2032

List of Tables

  • Table 1: Diagnosis of Diabetes
  • Table 2: Global: Diabetes Population Breakup by Country (in 000's), 2023 and 2032
  • Table 3: Japan: Total Prevalence & Number of Diabetes Patients, 2018, 2023 & 2032
  • Table 4: Japan (Type1 & Type2): Total Prevalence & Number of Diabetes Patients, 2018, 2023 & 2032
  • Table 5: Japan (Urban & Rural): Total Prevalence & Number of Diabetes Patients, 2018, 2023 & 2032
  • Table 6: Japan (Male & Female): Total Prevalence & Number of Diabetes Patients, 2018, 2023 & 2032
  • Table 7: Japan: Total Prevalence & Number of Diabetes Patients by Age Group (20-39, 40-59, 60-79 - In Millions), 2018, 2023 & 2032
  • Table 8: Japan: Diabetes Drug Market: Competitive Structure